Evidence map›Paper›PMID 42011110›Full record

ReviewHistology and histopathology2026

Glutamate signaling and transport around nodes of Ranvier and internodal myelin regions.

José Javier Miguel-Hidalgo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Histology and histopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

José Javier Miguel-HidalgoDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA. jmiguel-hidalgo@umc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The roles of glutamate as a major building block of proteins and as a key participant in numerous metabolic pathways are well established. Likewise, glutamate's function as a neurotransmitter-along with the distribution and actions of its receptors and reuptake mechanisms within the brain's gray matter-has been extensively characterized, leading to the development of existing and emerging treatments for neurological and psychiatric disorders. More recently, it has become clear that glutamate is also released in significant amounts within the white matter (WM), where it acts on specific receptors and is taken up by dedicated transporters. In the WM, glutamate is essential for activating receptors that support the development and maintenance of myelinated axons. Growing evidence further indicates that elevated extracellular glutamate or impaired glial reuptake in the WM can lead to pathological outcomes. Many of the receptors and transporters involved in glutamate signaling are located on astrocytic membranes and on the oligodendrocyte-derived myelin sheath, particularly concentrated at nodes of Ranvier and the adjacent paranodal and juxtaparanodal regions. This expanding understanding of glutamate-related mechanisms in the WM may ultimately pave the way for new therapeutic strategies targeting WM pathologies.

Indexed as

Glutamic AcidMyelin SheathRanvier's NodesSignal TransductionAnimalsHumansWhite MatterGlutamic Acid

Identifiers

PMID42011110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.